Intestinal integrity biomarkers in early antiretroviral-treated perinatally HIV-1-infected infants
The Journal of Infectious Diseases May 18, 2018
Koay WLA, et al. - Researchers compared early antiretroviral-treated, HIV-1-infected (HIV+; n=56) African infants and HIV-exposed but uninfected (HEU; n=53) controls in terms of biomarkers of intestinal integrity (intestinal fatty acid binding protein (iFABP) and zonulin). HIV+ infants demonstrated heightened inflammation and immune activation but were similar to HEU infants regarding iFABP and zonulin levels at three months of age. These levels were largely not correlated with inflammatory and immune activation biomarkers. However, by five months of age, zonulin levels increased and became significantly higher in HIV+ compared to HEU infants despite ART-suppression.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries